Identifying miRNA-mRNA regulatory relationships in breast cancer with invariant causal prediction

Vu Viet Hoang Pham, Junpeng Zhang, Lin Liu, Buu Minh Thanh Truong, Taosheng Xu, Trung T. Nguyen, Jiuyong Li, Thuc Duy Le

Abstract

Identifying causal regulatory relationships between microRNAs (miRNAs) and messenger RNAs (mRNAs) is essential for understanding breast cancer progression and developing targeted therapies. Traditional methods often struggle to distinguish between mere correlation and true causation, or they face significant computational hurdles. This paper introduces a novel framework based on Invariant Causal Prediction (ICP) that treats breast cancer subtypes as distinct environments to identify robust, causal interactions. The proposed hiddenICP-Pam50 method, particularly when integrated into an ensemble, demonstrates superior performance over existing state-of-the-art tools in validating against experimental ground-truth data.

Introduction

MicroRNAs (miRNAs) function as critical regulators of gene expression, acting as "dimmer switches" that can either promote tumor growth as oncogenes or inhibit it as tumor suppressors. Mapping the regulatory network between miRNAs and their target mRNAs is a central challenge in oncology. However, two primary obstacles persist: the difficulty of distinguishing correlation from causation and the high computational cost of inferring large-scale causal networks from limited sample sizes.

Methodology

The researchers developed a pipeline centered on the principle of Invariant Causal Prediction (ICP). The fundamental hypothesis is that a true causal relationship remains stable (invariant) across different biological contexts or "environments."

Environment Stratification and hiddenICP

The study utilized the Pam50 method to categorize breast cancer samples from The Cancer Genome Atlas (TCGA) into five subtypes: Basal, Her2, LumA, LumB, and Normal-like. These subtypes served as the distinct environments for the ICP algorithm. To address unobserved factors—such as transcription factors that might influence both miRNA and mRNA levels—the authors employed hiddenICP, an extension of the algorithm designed to account for hidden variables.

Ensemble Learning

To further enhance accuracy, the causal findings were combined with results from traditional statistical methods, including Pearson correlation and Lasso regression. An ensemble approach using a Borda election method was implemented to aggregate these "votes" and identify the most probable regulatory pairs.

Data Sources

The framework was trained and validated using high-quality genomic datasets:

  • TCGA BRCA: Expression profiles from 503 breast cancer samples.
  • Transfection Data (GEO): Experimental data involving miRNA introduction into cells, providing a "ground truth" for validation.
  • Validated Databases: Results were cross-referenced with experimentally confirmed interactions from miRTarbase, TarBase, and miRWalk.

Key Results

The hiddenICP-Pam50 method consistently outperformed other causal discovery methods, such as idaFast and jointIDA, when evaluated against experimental transfection data. The results highlight the effectiveness of treating cancer subtypes as experimental environments to filter out non-causal correlations.

Performance comparison of hiddenICP-Pam50 against other causal discovery and statistical methods across the top-ranked predicted interactions.

Furthermore, the ensemble method proved to be the most robust, suggesting that causal inference and traditional correlation provide complementary insights. Functional enrichment analysis of the identified targets revealed their involvement in critical pathways like Rap1 signaling and cell fate specification, both of which are known to drive breast cancer progression.

Discussion and Limitations

While the ICP-based approach offers a significant advancement in regulatory network inference, several limitations remain. The current model assumes linear relationships, which may not capture the full complexity of non-linear biological systems. Additionally, the requirement for sufficient sample sizes within each "environment" may limit the application of this method to rarer cancer types. Future work will focus on incorporating non-linear models and validating novel interactions through direct wet-lab experiments.

Summary updated

Abstract

Background microRNAs (miRNAs) regulate gene expression at the post-transcriptional level and they play an important role in various biological processes in the human body. Therefore, identifying their regulation mechanisms is essential for the diagnostics and therapeutics for a wide range of diseases. There have been a large number of researches which use gene expression profiles to resolve this problem. However, the current methods have their own limitations. Some of them only identify the correlation of miRNA and mRNA expression levels instead of the causal or regulatory relationships while others infer the causality but with a high computational complexity. To overcome these issues, in this study, we propose a method to identify miRNA-mRNA regulatory relationships in breast cancer using the invariant causal prediction. The key idea of invariant causal prediction is that the cause miRNAs of their target mRNAs are the ones which have persistent causal relationships with the target mRNAs across different environments. Results In this research, we aim to find miRNA targets which are consistent across different breast cancer subtypes. Thus, first of all, we apply the Pam50 method to categorize BRCA samples into different
BibTeX
@article{pham2019identifying,
  author = {Vu Viet Hoang Pham and Junpeng Zhang and Lin Liu and Buu Minh Thanh Truong and Taosheng Xu and Trung T. Nguyen and Jiuyong Li and Thuc Duy Le},
  title = {{Identifying miRNA-mRNA regulatory relationships in breast cancer with invariant causal prediction}},
  journal = {BMC Bioinformatics},
  year = {2019},
  doi = {10.1186/s12859-019-2668-x},
}
Figure